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delivery at 40 weeks gestation, three years prior to presentation. She
had no other medical problems. The patient appeared cachectic upon
arrival to her local hospital, and abdominal exam was consistent with
a 20-week size uterus. Ultrasound revealed an enlarged uterus ﬁlled
with echogenic material. Serum βhCG was found to be 900 mIU/mL.
The patient was transferred to our university hospital with ﬁndings
concerning for a complete molar pregnancy.
Upon transfer, ultrasound ﬁndings were conﬁrmed and serum
βhCG was repeated, revealing a value of 882 mIU/mL. The patientIntroduction
Hydatidiform molar pregnancy occurs as a proliferative disorder
of trophoblastic cells. Complete hydatidiform moles present with ab-
normally high levels of human chorionic gonadotropin (hCG); more
than 40% of patients have levels greater than 100,000 (Berkowitz &
Goldstein, 2009). Serum hCG may be misreported in cases of ex-
tremely high levels due to the “hook effect,”where falsely low or neg-
ative results occur from oversaturation of the signaling antibodies
employed to detect hCG by the testing equipment. Herein we de-
scribe a case where the hook effect was noted in a patient with a com-
plete hydatidiform mole.Case
A 27-year-old Latin-American female, P1001, presented to the
emergency department complaining of abdominal pain, persistent
nausea and vomiting for two weeks, and a twenty-pound weight
loss. The patient reported a positive home pregnancy test 16 weeks
prior to presentation, but had not presented for obstetric care. She
thought she had miscarried four weeks prior, with passage of a pro-
fuse amount of “jelly-like” substance, which had persisted.ncology, University of Alabama
, Birmingham, AL 35249, USA.
-ND license.was found to be thrombocytopenic with a platelet value of 95.1, ane-
mic with a hemoglobin value of 7.5, and coagulopathic with an INR of
2.2. After transfusion of packed red blood cells and fresh frozen plas-
ma, the patient was taken to the operating room for suction evacua-
tion of uterine contents. Pathology was consistent with a complete
hydatidiform mole. The patient developed preeclampsia with blood
pressures as high as 162/90, requiring magnesium prophylaxis. She
also developed hyperthyroidism with a TSH of b0.01 and free T4 of
2.97, requiring therapy with metoprolol.
The hospital laboratory was contacted and asked to perform serial
dilutions of the original βhCG sample, reported as 882 mIU/mL. Dilu-
tions were performed to 1:1600 and the βhCG result was recalculated
to be over 1,300,000 mIU/mL. On postoperative day 1, the βhCG fell to
326,175 mIU/mL, and was 13,035 mIU/mL on postoperative day 8. In
the days following evacuation, the patient's hyperemesis resolved
and hematologic parameters normalized. No evidence of metastasis
was seen on CT scans of the head, chest, abdomen, and pelvis. The
patient's βhCG continued to fall, but subsequently plateaued between
456 and 489 mIU/mL after approximately ten weeks, requiring ten
cycles of weekly methotrexate therapy dosed at 40 mg/m2. She has
now achieved a negative βhCG value, and has shown no evidence of
recurrence or metastasis.
Discussion
Human chorionic gonadotropin (hCG) is commonly used as a
marker for gestational trophoblastic disease. Total hCG levels greater
than 100,000 are highly suggestive of a complete hydatidiform mole
(Berkowitz & Goldstein, 2009). High hCG concentrations can give
low results, as the sensitivity of most hCG tests is set to the pregnancy
range of 27,300 to 233,000 at 8 to 11 weeks gestational age (Cole,
1997). Laboratory errors can occur with βhCG levels higher than
500,000 (Cole, 1997). Patients with hydatidiform molar pregnancies
often can present with extremely high HCG levels, reaching as high
as 3,000,000 (Muller & Cole, 2009). Serum testing is performed
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is present, it is immobilized by a capture antibody, and labeled by a
tracer antibody, resulting in an immobilized antibody-hCG-tracer
sandwich. When hCG levels are high, both the capture and tracer an-
tibodies saturate, and the signal response is decreased. The “hook ef-
fect” occurs when non-sandwiched tracer antibodies are washed
away with the excess material resulting in a falsely low or negative
test (Grenache et al., 2010). This may delay diagnosis and lead to mis-
management of patients. If molar pregnancy is suspected, the lab
should be asked to perform a 1:1000 dilution, with which an accurate
value should be obtained (Muller & Cole, 2009). This hook effect was
ﬁrst described by Miles et al. in 1976, and is more commonly seen in
assays for prolactin and thyroid stimulating hormone. The Advia Cen-
taur assay is used at our hospital, and has been shown in previous
studies to have dose-dependent falsely decreased results at hCG
concentrations greater than 940,000 (Grenache et al., 2010); this
effect is usually not signiﬁcant until concentrations are greater than
those typically seen in malignancy. Current hCG assays measure
non-nicked (biologically active) hCG and one of seven other combi-
nations of hCG-related molecules, attributing to variation in different
hCG assays (Cole, 1997).While rare, the hook effect can lead to delayed therapy or
mismanagement of care. Nevertheless, clinicians should be aware of
the limitations of laboratory measurements of extremely high levels
of hCG, understanding that falsely low or negative tests may arise
due to a hook effect, particularly in situations where a clinical
scenario may not correspond to a potentially falsely low laboratory
value.
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